Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis

BACKGROUND: Pancreatic cancer is a highly lethal disease with a poor prognosis while metformin has been associated with a decreased risk of pancreatic cancer. Although the benefit of metformin was observed for pancreatic cancer prevention, it is not clear whether it can also affect the survival of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ping-Ting, Li, Bo, Liu, Fu-Rao, Zhang, Mei-Chao, Wang, Qian, Li, Yan-Yan, Xu, Ci, Liu, Yuan-Hua, Yao, Yuan, Li, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421925/
https://www.ncbi.nlm.nih.gov/pubmed/28445955
http://dx.doi.org/10.18632/oncotarget.15692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421925/
https://www.ncbi.nlm.nih.gov/pubmed/28445955
http://dx.doi.org/10.18632/oncotarget.15692

Ejemplares similares